Investor Ideas ‘Potcast’; #Cannabis News
and Stocks on the Move; NYSE: $CGC, CSE: $ATT.C, CSE; $CHV.C, CSE: $LILY.C, TSXV: $HIP.V
Pt. Roberts, WA; Delta, BC – May 24, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source covering
leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of
its new series, Investorideas.com potcasts - cannabis news and stocks to watch plus
insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/05241Potcast-NYSECGCCSEATTCHVLILYTSXVHIP.asp
Today’s podcast overview/transcript: NYSE:
$CGC, CSE: $ATT.C, CSE; $CHV.C, CSE:
$LILY.C, TSXV: $HIP.V
Good afternoon and welcome to another Investorideas.com potcast –
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts. Today we are looking at announcements from Abattis Bioceuticals Corp. trading on the CSE as ATT and OTC as ATTBF, Canada House Wellness
Group Inc. trading on the CSE as CHV, Callitas Health Inc. trading on the CSE as LILY and the OTCQB as
MPHMF and Newstrike Resources Ltd. Trading on the TSXV as HIP.
But
first we take a look at Canopy Growth
Corporation trading on the TSX as WEED who announced that it expects its common
shares will begin trading under the ticker symbol "CGC" on the New
York Stock Exchange today.
This
listing follows a history of firsts for the Company including being the first
publicly traded, federally regulated cannabis company in North America, and the first to be included in the S&P/TSX Composite
index.
Next going to Abattis
Bioceuticals Corp. and its wholly-owned subsidiary, Vergence
Naturals Ltd. Who have launched their
“Live. Love. Life. Naturally!” marketing campaign to build awareness for their
naturally inspired health and beauty brands for the conventional and
cannabinoid-enhanced markets.
The campaign is designed to promote the products
and services of Vergence and the Company’s other affiliates. “We are very
pleased with the consistent progress being made through our marketing and
distribution arm, Vergence,” stated Rob Abenante, President and CEO of Abattis.
“With the appointment of Dr. Brazos Minshew as Head of the Company’s Medical
Advisory Board and President of Vergence’s Corporate Advisory Board, we look
forward to the development of new formulations and innovative natural products
for the conventional and cannabinoid-enhanced markets,” added Mr. Abenante.
Canada House Wellness Group Inc announced that it
has signed a Memorandum of Understanding (MOU) with The University of New
Brunswick (UNB) to provide researchers with opportunities to pursue the health
benefits of cannabis.
“We’re excited to be working with Canada House’s
team of medical, technological, scientific and business professionals to
further build on UNB’s status as the leading academic and research-based
university,” said Dr. David MaGee, vice-president of research at UNB.
Canada House is a diversified group of companies
with a broad range of expertise relating to the cannabis industry. Through
the partnership, UNB and Canada House hope to provide researchers with
opportunities to discover crucial information on the use of cannabis as a
medicinal product. It will also allow for shared technology research and
development and the exploration of shared education and outreach opportunities.
“We are pleased to be partnering with an academic
institution of such high reputation, and rich history, as UNB,” said Larry Bortles,
chair and CEO of Canada House. “As our industry continues to grow and expand,
we are very excited at the potential of what we will accomplish together to
change perceptions, not just in New Brunswick, but globally, of the efficacy of
medicinal cannabis and it’s wide range of curative potential.”
The MOU continues UNB’s commitment to strengthening
the provincial economy through innovative natural product research
Callitas Health Inc. an integrated clinical-stage
pharmaceutical development and OTC consumer goods marketing company, announced
today that it has signed an Exclusive Development and Intellectual Property
Agreement for its patent-pending CannaMint Strips. The Company has contracted
with a confidential OTC pharmaceutical development and custom packaging company
to help develop, contract manufacture and package the Company’s CannaMint
Strips for worldwide distribution. The confidential OTC pharmaceutical
company already has patented and patent-pending substrate technology for
extended release oral films that will further enhance the Callitas
patent-pending delivery.
The proprietary, patent and trademark-pending
CannaMint strips for THC and CBD provide a unique opportunity for Callitas to
position itself in the cannabinoids market. “Our patented and patent-pending
technologies have the potential to be game-changers as delivery mechanisms for
CBD and THC,” said James Thompson, Callitas’ Interim President and CEO.
In addition to the signed agreement, the Company
has filed additional trademarks for CannaStrips and
CanRelief. “Trademark protection for our additional cannabis-related
products not only protects our technology, but our shareholder’s investment and
long-term value as well,” Mr. Thompson said.
Finally Newstrike Resources Ltd announced that it
has entered into an agreement with a syndicate of investment dealers co-led by
Cormark Securities Inc. and INFOR Financial Inc. pursuant to which the
Underwriters have agreed to purchase 53,350,000 units from the treasury
of the Company, at a price of $0.75 per Unit and offer them to the public by
way of short form prospectus for total gross proceeds of approximately $40
million. Each Unit will consist of one common share of the Company and one-half
of one Common Share purchase warrant of the Company.
Each Warrant will entitle the holder thereof to
purchase one Common Share at a price equal to $1.00 for a period of 60 months
following the closing of the Offering.
The net proceeds of the Offering shall be used for
growth initiatives, working capital and general corporate purposes.
Investor ideas reminds all listeners to read
our disclaimers and disclosures
on the Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
on the Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
To sponsor this podcast or be a guest
Contact Investorideas.com
800-665-0411
